Biocon (BOM:532523) Days Sales Outstanding : 114.91 (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Biocon Days Sales Outstanding?

Biocon's average Accounts Receivable for the three months ended in Mar. 2025 was ₹54,879 Mil. Biocon's Revenue for the three months ended in Mar. 2025 was ₹43,581 Mil. Hence, Biocon's Days Sales Outstanding for the three months ended in Mar. 2025 was 114.91.

The historical rank and industry rank for Biocon's Days Sales Outstanding or its related term are showing as below:

BOM:532523' s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.02 Med: 80.45 Max: 144.26
Current: 144.26

During the past 13 years, Biocon's highest Days Sales Outstanding was 144.26. The lowest was 71.02. And the median was 80.45.

BOM:532523's Days Sales Outstanding is ranked worse than
80.8% of 849 companies
in the Biotechnology industry
Industry Median: 70.29 vs BOM:532523: 144.26

Biocon's Days Sales Outstanding declined from Mar. 2024 (147.15) to Mar. 2025 (114.91).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Biocon Days Sales Outstanding Historical Data

The historical data trend for Biocon's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Days Sales Outstanding Chart

Biocon Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Days Sales Outstanding

Get a 7-Day Free Trial

71.02

81.00

93.99

126.04

142.08

Biocon Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															147.15	168.40	157.77	148.23	114.91

Competitive Comparison of Biocon's Days Sales Outstanding

For the Biotechnology subindustry, Biocon's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocon's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocon's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biocon's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Biocon Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biocon's Days Sales Outstanding for the fiscal year that ended in Mar. 2025 is calculated as

	Days Sales Outstanding (A: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (62306	+	54879)	/	2 )	/	150522	*	365
=	58592.5					/	150522	*	365
=	142.08

Biocon's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (0	+	54879)	/	1 )	/	43581	*	365 / 4
=	54879					/	43581	*	365 / 4
=	114.91

Biocon (BOM:532523) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Biocon Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biocon's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (BOM:532523) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BIOCON:India

Address

20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560100

Website

https://www.biocon.com

Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Biosimilars which derives maximum revenue, Generics, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene. Geographically, the company generates a majority of its revenue from its customers located in India and the rest from Brazil, Singapore, and the rest of the world.

Biocon Headlines

No Headlines